mV25.html - Gods

mV25™ — Momentum to moVe™ | GODS.com

✓ C.L.E.A.N.
CERTIFIED

★ MADE IN
USA

◕ GMP
CERTIFIED

⌀ CYTOSOLVE®
OPTIMIZED™

◯ CytoSolve® OPTIMIZED™

Nutraceutical • Pain & Inflammation • Dr.SHIVA MIT PhD

mV25™ 86.59%

Momentum to moVe™

◆ CytoSolve® Formulated ✓ Certified CLEAN ◕ 60 Veg Capsules Patent US 17/011,83

mV25™ was formulated using the CytoSolve® computational systems biology platform — a technology for Precision and Personalized Medicine — invented by Dr.SHIVA during his doctoral research at MIT. This formulation results from integrating thousands of peer-reviewed scientific papers across 4 decades in 68 research institutions and computing trillions of potential combinations of biochemical reactions to discover an optimal synergy of compounds that downregulate the biomarkers of discomfort and normal swelling.†

CytoSolve® OPTIMIZED™ means this formula has been optimized to maximize efficacy and bioavailability while minimizing toxicity based on current research curated by CytoSolve®.† As the science advances, so will this formulation. This is our promise.

◆ Supplement Facts

Ingredient	Amount Per Serving	% DV
Serving Size: 2 Capsules • Servings: 30
Vitamin C (ascorbic acid)	60 mg	67%
Proprietary Blend:	1,030 mg	*
Hesperidin
Apigenin

* Daily value not established.
Other Ingredients: Microcrystalline cellulose, Capsule Shell (Hypromellose), Magnesium Stearate (Vegetable Source)

Buy mV25™ → View Solution Matrix

Patent No.: US 17/011,83 • Manufactured by VASHIVA, LLC • Cambridge, MA 02138

Overall Efficacy Score

86.59%

CytoSolve® Computed

Biomarkers Addressed

Molecular Targets

Pathways Modeled

Biological Cascades

Biological Processes

Disease Mechanisms

◆ CytoSolve® Computation

Solution Matrix & Scoring

Computed efficacy of mV25™ (Hesperidin 1,000mg + Apigenin 30mg + Vitamin C 60mg) for Joint Pain. Real simulation data from the CytoSolve® platform.

◆ Scoring Matrix

Hover a biomarker to highlight its hierarchy

Disease Name	Score	Biological Process	Score	Pathway Name	Score	Biomarker	Score
Joint Pain	86.59%	Oxidative Stress & Damage	31.13%	Oxidative Stress Pathway	31.13%	ROSDown	31.13%
		Inflammatory Pain Signaling	22.29%	COX-2 Synthesis	16.34%	COX-2Down	16.34%
		Inflammatory Pain Signaling	22.29%	Arachidonic Acid Metabolism	5.94%	PGE2Down	5.94%
		Neurogenic Pain & Nociception	33.17%	PGE2 Signaling_1	16.50%	TRPV1pDown	16.50%
		Neurogenic Pain & Nociception	33.17%	PGE2 Signaling_2	16.67%	CGRPDown	16.67%

◆ Solution Matrix — Simulation Data

Biological Process	Molecular Pathway	Biomarker	Direction	Control (nM)	Steady State (nM)	Basis
Oxidative Stress & Damage	Oxidative Stress Pathway	ROS	Down	16.863	1.114	simulated
Inflammatory Pain Signaling	COX-2 Synthesis	COX-2	Down	7.629	0.14916	simulated
Inflammatory Pain Signaling	Arachidonic Acid Metabolism	PGE2	Down	1,932.050	1,242.961	simulated
Neurogenic Pain & Nociception	PGE2 Signaling_1	TRPV1p	Down	0.05192	5.083e‑4	simulated
Neurogenic Pain & Nociception	PGE2 Signaling_2	CGRP	Down	0.27659	1.627e‑9	simulated

    ↓ Downregulate = beneficial decrease of the biomarker toward healthy levels. Applied compounds: Apigenin (30mg) + Hesperidin (1,000mg). Vitamin C not directly modeled in this run. All simulation data from CytoSolve® computational platform.
  

⋄ Active Compounds

Constituent Chemical Compounds

Three synergistic compounds computed by CytoSolve® to maximize joint health efficacy with minimal toxicity.

⋄

Hesperidin

C₂₈H₃₄O₁₅

A flavanone glycoside found in citrus fruits. Primary anti-inflammatory compound in mV25™. Strongly downregulates ROS, COX-2, and PGE2 biomarkers across multiple inflammatory pathways as computed by CytoSolve®.

◆ 1,000 mg per 2-capsule serving • Proprietary Blend

⋄

Apigenin

C₁₅H₁₀O₅

A natural flavone found in parsley, chamomile, and celery. Synergizes with Hesperidin in downregulating COX-2, TRPV1p, and CGRP — neurogenic pain markers identified in the CytoSolve® Joint Pain model.

◆ 30 mg per 2-capsule serving • Proprietary Blend

⋄

Vitamin C (Ascorbic Acid)

C₆H₈O₆

60 mg per serving (67% DV). Serves as an antioxidant co-factor enhancing bioavailability of the bioflavonoid blend while independently supporting oxidative stress defense.

◆ 60 mg / 67% DV • Standalone ingredient

◆ Real Results

What People Are Saying

Hear directly from people who have experienced mV25™ — CytoSolve® Optimized™ for joint comfort and mobility.

Testimonial Video

Replace with your video ↓

◆ mV25™ Customer Testimonial • Momentum to moVe™

✎ Replace this video: Paste your YouTube, Vimeo, or MP4 embed inside the .video-placeholder div above — add class has-video to hide the overlay.

† These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. CytoSolve® scores represent computational modeling outputs based on peer-reviewed research and do not constitute medical advice. Individual results may vary. Always consult a healthcare professional before starting any supplement regimen. Patent No.: US 17/011,83. mV25™ is a trademark of VASHIVA, LLC.